Topics in Clinical Microbiology
暂无分享,去创建一个
S. Mirrett | A. Hejazi | A Hejazi | F R Falkiner | F. Falkiner | C. W. Stratton | A Hejazi | F R Falkiner | Charles W. Stratton | RosemaryA. Verrall
[1] D. Straus,et al. Importance of a lipopolysaccharide-containing extracellular toxic complex in infections produced by Klebsiella pneumoniae , 1985, Infection and immunity.
[2] K. Omori,et al. The three genes lipB, lipC, and lipD involved in the extracellular secretion of the Serratia marcescens lipase which lacks an N-terminal signal peptide , 1995, Journal of bacteriology.
[3] W. Martone,et al. Epidemic septic arthritis caused by Serratia marcescens and associated with a benzalkonium chloride antiseptic , 1987, Journal of clinical microbiology.
[4] D. Livermore,et al. Characterization of an LysR family protein, SmeR from Serratia marcescens S6, its effect on expression of the carbapenem-hydrolyzing beta-lactamase Sme-1, and comparison of this regulator with other beta-lactamase regulators , 1995, Antimicrobial agents and chemotherapy.
[5] R. Hancock,et al. Novel method for measurement of outer membrane permeability to new beta-lactams in intact Enterobacter cloacae cells , 1991, Antimicrobial Agents and Chemotherapy.
[6] R. P. Williams,et al. Induction of Pigmentation in Nonproliferating Cells of Serratia marcescens by Addition of Single Amino Acids , 1971, Journal of bacteriology.
[7] I. Slotki,et al. Prevention of scarring in experimental pyelonephritis in the rat by early antibiotic therapy. , 1982, Nephron.
[8] P. Gerner-Smidt,et al. Nosocomial epidemic of Serratia marcescens septicemia ascribed to contaminated blood transfusion bags , 1993, Transfusion.
[9] Y. Xiong,et al. In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis , 1994, Antimicrobial Agents and Chemotherapy.
[10] F. Grimont,et al. Ribosomal ribonucleic acid gene restriction patterns as potential taxonomic tools. , 1986, Annales de l'Institut Pasteur. Microbiology.
[11] C. Henquell,et al. Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem , 1993, Journal of clinical microbiology.
[12] S. Létoffé,et al. Identification of two components of the Serratia marcescens metalloprotease transporter: protease SM secretion in Escherichia coli is TolC dependent , 1993, Journal of bacteriology.
[13] C. Watanakunakorn,et al. Emergence of resistance to imipenem in Enterobacter isolates masquerading as Klebsiella pneumoniae during therapy with imipenem/cilastatin. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] M. Rosenberg,et al. Effect of Cetylpyridinium Chloride on Microbial Adhesion to Hexadecane and Polystyrene , 1990, Applied and environmental microbiology.
[15] A. Hejazi,et al. The use of RAPD-PCR as a typing method for Serratia marcescens. , 1997, Journal of medical microbiology.
[16] A. Wardlaw,et al. Growth and survival of Bordetella bronchiseptica in natural waters and in buffered saline without added nutrients , 1991, Applied and environmental microbiology.
[17] H. Chetoui,et al. Ribotyping for use in studying molecular epidemiology of Serratia marcescens: comparison with biotyping , 1995, Journal of clinical microbiology.
[18] Y. Mizunoe,et al. Effect of pili of Serratia marcescens on superoxide production and phagocytosis of human polymorphonuclear leukocytes. , 1995, The Journal of urology.
[19] M. Viñas,et al. The role of O-antigen in susceptibility of Serratia marcescens to non-immune serum. , 1993, Microbios.
[20] J. Billé,et al. Protection against chronic pyelonephritis in rats by suppression of acute suppuration: effect of colchicine and neutropenia. , 1982, The Journal of infectious diseases.
[21] P S Cohen,et al. Infective endocarditis caused by gram-negative bacteria: a review of the literature, 1945-1977. , 1980, Progress in cardiovascular diseases.
[22] Claude Carbón. Impact of the antibiotic dosage schedule on efficacy in experimental endocarditis. , 1990, Scandinavian journal of infectious diseases. Supplementum.
[23] R. Harshey,et al. Mutations that impair swarming motility in Serratia marcescens 274 include but are not limited to those affecting chemotaxis or flagellar function , 1992, Journal of bacteriology.
[24] C. Kunin,et al. Control of a single source nursery epidemic due to Serratia marcescens. , 1966, Pediatrics.
[25] A. Bisno,et al. Epidemic Serratia marcescens in a Neonatal Intensive Care Unit: Importance of the Gastrointestinal Tract as a Reservoir , 1982, Infection Control.
[26] R. Coria-Jiménez,et al. Aminoglycoside resistance patterns of Serratia marcescens strains of clinical origin , 1994, Epidemiology and Infection.
[27] L. Papazian,et al. A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive care. , 1993, The Journal of antimicrobial chemotherapy.
[28] J. Hows,et al. Ciprofloxacin resistant Serratia marcescens endocarditis as a complication of non-Hodgkin's lymphoma. , 1994, The Journal of infection.
[29] A. Zuckerman,et al. INFECTION DUE TO CHROMOBACTERIA: Report of Eleven Cases , 1951 .
[30] M. Silverman,et al. Effect of Iron and Salt on Prodigiosin Synthesis in Serratia marcescens , 1973, Journal of bacteriology.
[31] E. Reese,et al. The chitinase of Serratia marcescens. , 1969, Canadian journal of microbiology.
[32] V L Yu,et al. Serratia marcescens: historical perspective and clinical review. , 1979 .
[33] A. Bhasin,et al. Mutational analysis of flagellum-independent surface spreading of Serratia marcescens 274 on a low-agar medium , 1995, Journal of Bacteriology.
[34] W. J. Martin,et al. Serratia marcescens: Biochemical Characteristics, Antibiotic Susceptibility Patterns, and Clinical Significance , 1970 .
[35] D. Oxley,et al. Structures of neutral glycans isolated from the lipopolysaccharides of reference strains for Serratia marcescens serogroups O16 and O20. , 1989, Carbohydrate research.
[36] D. Sordelli,et al. An 8-year study of resistance to amikacin in gram-negative bacilli isolates from patients with nosocomial infection at one hospital in Argentina. , 1995, Journal of medical microbiology.
[37] O. Kwon,et al. In-vitro activities of cefepime against Enterobacter cloacae, Serratia marcescens, Pseudomonas aeruginosa and other aerobic gram-negative bacilli. , 1993, The Journal of antimicrobial chemotherapy.
[38] S. Mudd,et al. THE PENETRATION OF BACTERIA THROUGH CAPILLARY SPACES : IV. A KINETIC MECHANISM IN INTERFACES. , 1924 .
[39] W. Traub. Serotyping of Serratia marcescens: detection of two new O-antigens (O25 and O26). , 1991, Zentralblatt fur Bakteriologie : international journal of medical microbiology.
[40] T. Stenström,et al. Growth and survival of Serratia marcescens under aerobic and anaerobic conditions in the presence of materials from blood bags , 1993, Journal of clinical microbiology.
[41] R. Sautter,et al. Serratia Marcescens Meningitis Associated With a Contaminated Benzalkonium Chloride Solution , 1984, Infection Control.
[42] P. Nordmann,et al. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli , 1993, Antimicrobial Agents and Chemotherapy.
[43] R. Fuchs,et al. Cloning of a Serratia marcescens Gene Encoding Chitinase , 1986, Applied and environmental microbiology.
[44] C. Hogman,et al. The role of white cells in the transmission of Yersinia enterocolitica in blood components , 1992, Transfusion.
[45] J. Costerton,et al. Prolonged survival of Serratia marcescens in chlorhexidine , 1981, Applied and environmental microbiology.
[46] R. P. Williams,et al. Influence of Temperature of Incubation and Type of Growth Medium on Pigmentation in Serratia marcescens , 1971, Journal of bacteriology.
[47] G. Ihler,et al. Genetic analysis of extracellular proteins of Serratia marcescens , 1988, Journal of bacteriology.
[48] J. Sleigh. Antibiotic resistance in Serratia marcescens. , 1983, British medical journal.
[49] D. Woodfield. Transfusion acquired Serratia liquefaciens septicaemia. , 1991, The New Zealand medical journal.
[50] D. Livermore,et al. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A beta-lactamase, Sme-1, from Serratia marcescens S6 , 1994, Antimicrobial Agents and Chemotherapy.
[51] J. Tsang,et al. Enhancement by Sodium Dodecyl Sulfate of Pigment Formation in Serratia marcescens O8 , 1982, Applied and environmental microbiology.
[52] C. Whitfield,et al. Relationships between rfb gene clusters required for biosynthesis of identical D-galactose-containing O antigens in Klebsiella pneumoniae serotype O1 and Serratia marcescens serotype O16 , 1995, Journal of bacteriology.
[53] T. Pitt,et al. Improved O-serotyping method for Serratia marcescens , 1989, Journal of clinical microbiology.
[54] E. G. Allen. Conditions of the Colour Change of Prodigiosin , 1967, Nature.
[55] D Drew,et al. Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse. , 1976, Annals of internal medicine.
[56] C. Hogman,et al. Transfusion‐associated Serratia marcescens infection: studies of the mechanism of action , 1993, Transfusion.
[57] M. Walder,et al. Persistance of Serratia marcescens, Serratia liquefaciens and E. coli in solutions for contact lenses , 1986, Acta ophthalmologica.
[58] J. Sobel,et al. Bacterial adherence in the pathogenesis of urinary tract infection: a review. , 1987, Reviews of infectious diseases.
[59] Y. Arakawa,et al. Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens , 1995, Antimicrobial agents and chemotherapy.
[60] K. van Pée,et al. Purification and properties of a non-haem chloroperoxidase from Serratia marcescens. , 1995, FEMS microbiology letters.
[61] R. Harshey,et al. Differentiation of Serratia marcescens 274 into swimmer and swarmer cells , 1990, Journal of bacteriology.
[62] E. Denamur,et al. Ribotyping provides efficient differentiation of nosocomial Serratia marcescens isolates in a pediatric hospital , 1992, Journal of clinical microbiology.
[63] N. J. Ehrenkranz,et al. ANTIBIOTIC-SENSITIVE SERRATIA MARCESCENS INFECTIONS COMPLICATING CARDIOPULMONARY OPERATIONS: CONTAMINATED DISINFECTANT AS A RESERVOIR , 1980, The Lancet.
[64] S. Létoffé,et al. Secretion of the Serratia marcescens HasA protein by an ABC transporter , 1994, Journal of bacteriology.
[65] C. Hogman,et al. White cells protect donor blood against bacterial contamination , 1991, Transfusion.
[66] C. Cox. Aztreonam therapy for complicated urinary tract infections caused by multidrug-resistant bacteria. , 1985, Reviews of infectious diseases.
[67] R. Charrel,et al. Serratia marcescens nosocomial outbreak due to contamination of hexetidine solution. , 1996, The Journal of hospital infection.
[68] N. Kaplan,et al. DNA from Serratia marcescens confers a hydrophobic character in Escherichia coli. , 1995, FEMS microbiology letters.
[69] R. Wenzel,et al. Catheter-associated bacteriuria. Failure to reduce attack rates using periodic instillations of a disinfectant into urinary drainage systems. , 1984 .
[70] A. Ellingboe,et al. Molecular cloning of two chitinase genes from Serratia marcescens and their expression in Pseudomonas species , 1988 .
[71] M. Viñas,et al. Serratia marcescens adherence: the effect of O-antigen presence. , 1995, Microbios.
[72] K. Livak,et al. DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. , 1990, Nucleic acids research.
[73] D. Craven,et al. Serratia marcescens contamination of antiseptic soap containing triclosan: implications for nosocomial infection. , 1984, Infection control : IC.
[74] I. N. Andreeva,et al. Effect of various growth conditions on pigmentation of Serratia marcescens. , 1994, Microbios.
[75] W. Liu,et al. Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents , 1990, Antimicrobial Agents and Chemotherapy.
[76] T. Pitt,et al. O-antigen specificities of the serotype strains of Serratia marcescens , 1989, Journal of clinical microbiology.
[77] F. Baquero,et al. Comparison of serotype, biotype and bacteriocin type with rDNA RFLP patterns for the type identification of Serratia marcescens , 1993, Epidemiology and Infection.
[78] A. P. Ball,et al. Serratia marcescens in a general hospital. , 1977, The Quarterly journal of medicine.
[79] F. Grimont,et al. Nosocomial Serratia marcescens individualized by five typing methods in a regional hospital. , 1990, The Journal of hospital infection.
[80] W. Blakemore,et al. Serratia marcescens. A pathogen of increasing clinical importance. , 1970, JAMA.
[81] T. Pitt,et al. Infection with netilmicin resistant Serratia marcescens in a special care baby unit. , 1983, British medical journal.
[82] F. Grimont,et al. Biotyping of Serratia marcescens and its use in epidemiological studies , 1978, Journal of clinical microbiology.
[83] M. Cheung,et al. Use of PCR to study epidemiology of Serratia marcescens isolates in nosocomial infection , 1994, Journal of clinical microbiology.
[84] K. Kaneda,et al. A novel extracellular cyclic lipopeptide which promotes flagellum-dependent and -independent spreading growth of Serratia marcescens , 1992, Journal of bacteriology.
[85] W. Martone,et al. Survival of Serratia marcescens in benzalkonium chloride and in multiple-dose medication vials: relationship to epidemic septic arthritis , 1987, Journal of clinical microbiology.
[86] F. Yoshimura,et al. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance , 1994, Antimicrobial Agents and Chemotherapy.
[87] P. Hawkey,et al. Selection of netilmicin resistance, associated with increased 6' aminoglycoside acetyltransferase activity, in Serratia marcescens. , 1988, The Journal of antimicrobial chemotherapy.
[88] J M Lyons,et al. Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. , 1978, The Journal of clinical investigation.
[89] K. A. Merendino,et al. Serratia marcescens endocarditis. A review of the literature and report of a case involving a homograft replacement of the aortic valve. , 1969, Archives of surgery.
[90] V. Eijsink,et al. Characterization of a chitinase gene (chiA) from Serratia marcescens BJL200 and one-step purification of the gene product. , 1994, FEMS microbiology letters.
[91] M. Rosenberg,et al. Mechanism of enhancement of microbial cell hydrophobicity by cationic polymers , 1990, Journal of bacteriology.
[92] K. Joiner. Studies on the mechanism of bacterial resistance to complement-mediated killing and on the mechanism of action of bactericidal antibody. , 1985, Current topics in microbiology and immunology.
[93] M. Rosenberg,et al. Cell surface hydrophobicity of pigmented and nonpigmented clinical Serratia marcescens strains , 1986, Infection and immunity.
[94] I. Yano,et al. Extracellular Vesicle Formation and Biosurfactant Production by Serratia marcescens , 1986 .
[95] T. Pitt. State of the art: typing of Serratia marcescens. , 1982, The Journal of hospital infection.
[96] M. Viñas,et al. Lipopolysaccharide recovery restores susceptibility levels towards beta-lactams in Serratia marcescens. , 1995, Microbios.